oxymetazoline has been researched along with Rhinitis in 47 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
Rhinitis: Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to summarise the evidence for efficacy of combination treatment of intranasal corticosteroid spray with oxymetazoline hydrochloride nasal spray for chronic rhinitis." | 9.22 | Intranasal corticosteroid and oxymetazoline for chronic rhinitis: a systematic review. ( Camacho, M; Neighbors, CL; Salvador, CF; Tsai, P; Zhu, B, 2022) |
| "We sought to explore the benefit of oxymetazoline (Oxymet) plus INS on nasal congestion without inducing rhinitis medicamentosa." | 9.22 | The effectiveness of oxymetazoline plus intranasal steroid in the treatment of chronic rhinitis: A randomised controlled trial. ( Assanasen, P; Pradubpongsa, P; Tantilipikorn, P; Thongngarm, T, 2016) |
| "A prospective placebo-controlled double-blind study investigated the question whether oxymetazoline has a clinically relevant impact on the duration of acute rhinitis." | 9.11 | [Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis]. ( Reinecke, S; Tschaikin, M, 2005) |
| "This randomised, double-blind, multi-centered, verum-controlled tolerance study confirmed that the local sympathomimetics oxymetazoline and xylometazoline are well tolerated in the treatment of acute rhinitis." | 9.10 | [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis]. ( Dorn, M; Hofmann, W; Knick, E, 2003) |
| "A new administration form of the nasal decongestant oxymetazoline and its effects on maxillary ostial patency were investigated in 5 healthy individuals and 20 patients with acute rhinitis." | 9.07 | Effects of a new administration form of oxymetazoline on maxillary ostial patency in healthy individuals and patients with acute rhinitis. ( Ackerhans, M; Jannert, M; Tönnesson, M, 1994) |
| "The absolute bioavailability (f) and pharmacokinetics of transnasal butorphanol were evaluated in patients experiencing rhinitis." | 9.07 | The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis. ( Barbhaiya, RH; Pittman, KA; Robinson, DS; Shyu, WC, 1993) |
| "According to the results, xylitol solution is effective as mometasone, usable and well-priced in the treatment of rhinitis medicamentosa." | 7.91 | Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study. ( Cam, B; Gergin, O; Midi, A; Sari, M, 2019) |
| "This study aimed to summarise the evidence for efficacy of combination treatment of intranasal corticosteroid spray with oxymetazoline hydrochloride nasal spray for chronic rhinitis." | 5.22 | Intranasal corticosteroid and oxymetazoline for chronic rhinitis: a systematic review. ( Camacho, M; Neighbors, CL; Salvador, CF; Tsai, P; Zhu, B, 2022) |
| "We sought to explore the benefit of oxymetazoline (Oxymet) plus INS on nasal congestion without inducing rhinitis medicamentosa." | 5.22 | The effectiveness of oxymetazoline plus intranasal steroid in the treatment of chronic rhinitis: A randomised controlled trial. ( Assanasen, P; Pradubpongsa, P; Tantilipikorn, P; Thongngarm, T, 2016) |
| "A prospective placebo-controlled double-blind study investigated the question whether oxymetazoline has a clinically relevant impact on the duration of acute rhinitis." | 5.11 | [Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis]. ( Reinecke, S; Tschaikin, M, 2005) |
| "This randomised, double-blind, multi-centered, verum-controlled tolerance study confirmed that the local sympathomimetics oxymetazoline and xylometazoline are well tolerated in the treatment of acute rhinitis." | 5.10 | [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis]. ( Dorn, M; Hofmann, W; Knick, E, 2003) |
| "A randomized double-blind parallel study with 20 healthy volunteers was performed to examine the effect of oxymetazoline nasal spray on the development of rhinitis medicamentosa." | 5.08 | Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity. ( Graf, P; Hallén, H; Juto, JE, 1995) |
| "A new administration form of the nasal decongestant oxymetazoline and its effects on maxillary ostial patency were investigated in 5 healthy individuals and 20 patients with acute rhinitis." | 5.07 | Effects of a new administration form of oxymetazoline on maxillary ostial patency in healthy individuals and patients with acute rhinitis. ( Ackerhans, M; Jannert, M; Tönnesson, M, 1994) |
| "The absolute bioavailability (f) and pharmacokinetics of transnasal butorphanol were evaluated in patients experiencing rhinitis." | 5.07 | The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis. ( Barbhaiya, RH; Pittman, KA; Robinson, DS; Shyu, WC, 1993) |
| "According to the results, xylitol solution is effective as mometasone, usable and well-priced in the treatment of rhinitis medicamentosa." | 3.91 | Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study. ( Cam, B; Gergin, O; Midi, A; Sari, M, 2019) |
| "The nasal decongestant oxymetazoline (OMZ) is frequently used in the topical treatment of rhinitis/sinusitis." | 3.74 | Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells. ( Jonuleit, H; Knop, J; Koelsch, S; Tuettenberg, A, 2007) |
| "105 patients collected from chronic simple rhinitis, chronic hypertrophic rhinitis and perennial allergic rhinitis were treated with daphnlin spray (daphnlin group) or ephedrine spray (ephedrine group)." | 3.70 | [The curative effect of daphnlin spray on treating rhinitis]. ( Huang, X; Tan, H; Yue, J, 1999) |
| "The aim was to study changes in sales and prescribing of nasal decongestants containing oxymetazoline or xylometazoline, changes in number of physician visits for rhinitis and sinusitis, and changes in public expenditures for physician visits due to the switch of these drugs from prescription to over-the-counter status in Sweden in 1989." | 3.70 | The impact of over-the-counter availability of nasal sprays on sales, prescribing, and physician visits. ( Isacson, D; Lundberg, L, 1999) |
| " In conclusion, the long-term use of benzalkonium chloride in oxymetazoline nasal spray accentuates the severity of rhinitis medicamentosa in healthy volunteers." | 2.68 | Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. ( Graf, P; Hallén, H; Juto, JE, 1995) |
| " It is concluded that a nasal decongestant spray composed of a combination of vasoactive substance and benzalkonium chloride has a long-term adverse effect on the nasal mucosa." | 2.68 | Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers. ( Graf, P; Hallén, H, 1995) |
| " Long-term use of placebo and benzalkonium chloride nasal sprays also caused an increase in nasal reactivity, but not to the same extent as with the nasal sprays containing oxymetazoline." | 2.68 | Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. ( Graf, P; Hallén, H, 1996) |
| "Our aim in this study is to reveal the expression of Vascular Endothelial Growth Factor (VEGF) and Inducible Nitric Oxide Synthase (iNOS) in the pathogenesis of rhinitis medicamentosa (RM), which occurs as a result of the overdose and long-term use of topical nasal decongestants." | 1.72 | The importance of vascular epithelial growth factor (VEGF) and inducible nitric oxide synthase (INOS) in rhinitis medicamentosa pathogenesis: An experimental rat model study. ( Bulut, F; Cumbul, A, 2022) |
| "Oxymetazoline or Salbutamol were prescribed according to best clinical practice guidelines." | 1.46 | Efficacy and usability of a novel nebulizer targeting both upper and lower airways. ( Hofmaier, S; Lau, S; Matricardi, PM; Perna, S; Pizzulli, A; Posa, D; Wagner, P, 2017) |
| "Nasal obstruction is caused by rebound swelling when the decongestive effect has disappeared." | 1.33 | [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa]. ( Bloching, M; Holzhausen, HJ; Knipping, S; Riederer, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (29.79) | 18.7374 |
| 1990's | 14 (29.79) | 18.2507 |
| 2000's | 10 (21.28) | 29.6817 |
| 2010's | 5 (10.64) | 24.3611 |
| 2020's | 4 (8.51) | 2.80 |
| Authors | Studies |
|---|---|
| Neighbors, CL | 1 |
| Salvador, CF | 1 |
| Zhu, B | 1 |
| Camacho, M | 1 |
| Tsai, P | 1 |
| Cumbul, A | 1 |
| Bulut, F | 1 |
| Cam, B | 1 |
| Sari, M | 1 |
| Midi, A | 1 |
| Gergin, O | 1 |
| Cengiz, B | 1 |
| Bostancıklıoğlu, M | 1 |
| Demir, T | 1 |
| Karabulut, H | 1 |
| Dokuyucu, R | 1 |
| Ulaşlı, M | 1 |
| Shakhova, EG | 1 |
| Posa, D | 1 |
| Pizzulli, A | 1 |
| Wagner, P | 1 |
| Perna, S | 1 |
| Hofmaier, S | 1 |
| Matricardi, PM | 1 |
| Lau, S | 1 |
| Thongngarm, T | 1 |
| Assanasen, P | 1 |
| Pradubpongsa, P | 1 |
| Tantilipikorn, P | 1 |
| Fabi, M | 1 |
| Formigari, R | 1 |
| Picchio, FM | 1 |
| Tüttenberg, A | 1 |
| Bielenberg, J | 1 |
| Yue, J | 1 |
| Huang, X | 1 |
| Tan, H | 1 |
| SLODKI, SJ | 1 |
| MONTGOMERY, CA | 1 |
| Dorn, M | 1 |
| Hofmann, W | 1 |
| Knick, E | 1 |
| Reinecke, S | 2 |
| Tschaikin, M | 2 |
| Knipping, S | 1 |
| Holzhausen, HJ | 1 |
| Riederer, A | 1 |
| Bloching, M | 1 |
| Tuettenberg, A | 1 |
| Koelsch, S | 1 |
| Knop, J | 1 |
| Jonuleit, H | 1 |
| Straszek, SP | 1 |
| Schlünssen, V | 1 |
| Sigsgaard, T | 1 |
| Pedersen, OF | 1 |
| Bende, M | 2 |
| Ekedahl, C | 2 |
| Geterud, A | 3 |
| Petruson, B | 2 |
| Aust, R | 2 |
| Odkvist, L | 2 |
| Rundcrantz, H | 1 |
| Graf, P | 5 |
| Hallén, H | 4 |
| Juto, JE | 2 |
| Wilhelmson, B | 1 |
| Ackerhans, M | 1 |
| Jannert, M | 1 |
| Tönnesson, M | 1 |
| Shyu, WC | 1 |
| Pittman, KA | 1 |
| Robinson, DS | 1 |
| Barbhaiya, RH | 1 |
| Yoo, JK | 1 |
| Seikaly, H | 1 |
| Calhoun, KH | 1 |
| Hummel, T | 1 |
| Rothbauer, C | 1 |
| Pauli, E | 1 |
| Kobal, G | 1 |
| Lundberg, L | 1 |
| Isacson, D | 1 |
| Dowley, AC | 1 |
| Homer, JJ | 1 |
| Inanli, S | 1 |
| Oztürk, O | 1 |
| Korkmaz, M | 1 |
| Tutkun, A | 1 |
| Batman, C | 1 |
| Redemsky, J | 1 |
| Hansell, P | 1 |
| Intaglietta, M | 1 |
| Arfors, KE | 1 |
| Howarth, P | 1 |
| Walsh, S | 1 |
| Robinson, C | 1 |
| Osguthorpe, JD | 1 |
| Shirley, R | 1 |
| Blakley, BW | 1 |
| Wilson, KS | 1 |
| Rüggeberg, F | 1 |
| Ten Eyck, TG | 1 |
| Schleuning, A | 1 |
| Stride, RD | 1 |
| Neffson, AH | 1 |
| Connell, JT | 1 |
| Neidorff, AH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Proof of Concept Study to Evaluate if Concomitant Topical Intranasal Steroid Prevents Tolerance and Rebound Congestion Due to Regular Oxymetazoline in Persistent Allergic Rhinitis.[NCT00846326] | Phase 4 | 0 participants (Actual) | Interventional | Withdrawn (stopped due to The suppliers were unable to provide the investigational medicinal product (IMP)) | |||
| A Proof of Concept Study to Evaluate Differential Tachyphylaxis of Alpha 1 and Alpha 2 Adrenoreceptor Mediated Decongestant Response to Oxymetazoline and Its Acute Reversal by Corticosteroid in Healthy Volunteers[NCT00487032] | Phase 4 | 19 participants (Actual) | Interventional | 2008-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for oxymetazoline and Rhinitis
| Article | Year |
|---|---|
Intranasal corticosteroid and oxymetazoline for chronic rhinitis: a systematic review.
Topics: Administration, Intranasal; Chronic Disease; Glucocorticoids; Humans; Nasal Decongestants; Oxymetazo | 2022 |
21 trials available for oxymetazoline and Rhinitis
| Article | Year |
|---|---|
[Comparative study of the efficacy of combined nasal topical drug and topical decongestants in the treatment of acute rhinosinusitis].
Topics: Administration, Intranasal; Adolescent; Adult; Double-Blind Method; Female; Humans; Male; Middle Age | 2020 |
The effectiveness of oxymetazoline plus intranasal steroid in the treatment of chronic rhinitis: A randomised controlled trial.
Topics: Administration, Intranasal; Adult; Budesonide; Chronic Disease; Double-Blind Method; Drug Therapy, C | 2016 |
[Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
Topics: Acute Disease; Administration, Intranasal; Adult; Aerosols; Benzalkonium Compounds; Common Cold; Dou | 2003 |
[Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis].
Topics: Acute Disease; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Nasal Decongestants; O | 2005 |
[Investigation of the effect of oxymetazoline on the duration of rhinitis].
Topics: Adolescent; Adult; Child; Double-Blind Method; Female; Humans; Male; Nasal Decongestants; Nasal Obst | 2005 |
A comparative preference study between xylometazoline nasal dose spray (Otrivin) and oxymetazoline single-dose pipettes (Nezeril).
Topics: Adult; Clinical Trials as Topic; Female; Humans; Imidazoles; Male; Nasal Decongestants; Oxymetazolin | 1983 |
[Comparison between xylometazoline in a dosage spray and oxymetazoline in one dose pipettes].
Topics: Adult; Aerosols; Clinical Trials as Topic; Female; Humans; Imidazoles; Male; Middle Aged; Oxymetazol | 1983 |
Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
Topics: Administration, Intranasal; Adult; Aerosols; Benzalkonium Compounds; Double-Blind Method; Female; Hu | 1995 |
Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers.
Topics: Administration, Intranasal; Adult; Aerosols; Benzalkonium Compounds; Double-Blind Method; Drug Admin | 1995 |
Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
Topics: Administration, Intranasal; Adult; Double-Blind Method; Female; Humans; Hypersensitivity; Male; Nasa | 1995 |
Effects of a new administration form of oxymetazoline on maxillary ostial patency in healthy individuals and patients with acute rhinitis.
Topics: Acute Disease; Administration, Intranasal; Double-Blind Method; Female; Humans; Male; Maxillary Sinu | 1994 |
The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.
Topics: Absorption; Administration, Intranasal; Adult; Biological Availability; Butorphanol; Drug Interactio | 1993 |
Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
Topics: Administration, Intranasal; Adolescent; Adult; Benzalkonium Compounds; Double-Blind Method; Female; | 1996 |
Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
Topics: Administration, Intranasal; Adult; Benzalkonium Compounds; Double-Blind Method; Drug Tolerance; Fema | 1996 |
Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
Topics: Administration, Intranasal; Adult; Benzalkonium Compounds; Double-Blind Method; Drug Tolerance; Fema | 1996 |
Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
Topics: Administration, Intranasal; Adult; Benzalkonium Compounds; Double-Blind Method; Drug Tolerance; Fema | 1996 |
Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
Topics: Administration, Intranasal; Adult; Benzalkonium Compounds; Double-Blind Method; Drug Tolerance; Fema | 1996 |
Extended use of topical nasal decongestants.
Topics: Humans; Nasal Decongestants; Nasal Obstruction; Oxymetazoline; Rhinitis; Sympathomimetics | 1997 |
Extended use of topical nasal decongestants.
Topics: Humans; Nasal Decongestants; Nasal Obstruction; Oxymetazoline; Rhinitis; Sympathomimetics | 1997 |
Extended use of topical nasal decongestants.
Topics: Humans; Nasal Decongestants; Nasal Obstruction; Oxymetazoline; Rhinitis; Sympathomimetics | 1997 |
Extended use of topical nasal decongestants.
Topics: Humans; Nasal Decongestants; Nasal Obstruction; Oxymetazoline; Rhinitis; Sympathomimetics | 1997 |
Effects of the nasal decongestant oxymetazoline on human olfactory and intranasal trigeminal function in acute rhinitis.
Topics: Acute Disease; Adult; Double-Blind Method; Female; Humans; Male; Nasal Decongestants; Olfactory Nerv | 1998 |
The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus.
Topics: Administration, Intranasal; Aerosols; Cross-Over Studies; Humans; Hypertrophy; Nasal Cavity; Nasal D | 2001 |
The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Aged; Analysis of Variance; Androstadiene | 2002 |
[Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)].
Topics: Clinical Trials as Topic; Humans; Imidazoles; Infant; Nasal Decongestants; Oxymetazoline; Rhinitis; | 1974 |
Effectiveness of topical nasal decongestants.
Topics: Adolescent; Adult; Airway Resistance; Clinical Trials as Topic; Common Cold; Female; Humans; Male; M | 1969 |
Clinical note: double-blind comparison of the duration of effect of oxymetazoline and phenylephrine in children.
Topics: Asthma; Child, Preschool; Clinical Trials as Topic; Humans; Infant; Oxymetazoline; Phenylephrine; Rh | 1966 |
25 other studies available for oxymetazoline and Rhinitis
| Article | Year |
|---|---|
The importance of vascular epithelial growth factor (VEGF) and inducible nitric oxide synthase (INOS) in rhinitis medicamentosa pathogenesis: An experimental rat model study.
Topics: Animals; Edema; Nasal Mucosa; Nitric Oxide Synthase Type II; Oxymetazoline; Rats; Rats, Wistar; Rhin | 2022 |
Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.
Topics: Administration, Intranasal; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Male; Mometas | 2019 |
Investigation of Cytotoxic Effects of Oxymetazoline on Lungs in a Rat Model of Rhinitis Medicamentosa.
Topics: Animals; Lung; Nasal Decongestants; Oxymetazoline; Rats; Rats, Wistar; Rhinitis | 2021 |
Efficacy and usability of a novel nebulizer targeting both upper and lower airways.
Topics: Administration, Inhalation; Adolescent; Albuterol; Ambulatory Care Facilities; Asthma; Bronchodilato | 2017 |
Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope.
Topics: Bradycardia; Diagnosis, Differential; Echocardiography; Electrocardiography; Humans; Infant; Male; N | 2009 |
Best drugs for what ails you: the brands to buy--and those to skip.
Topics: Acetaminophen; Anesthetics, Local; Cetirizine; Chlorpheniramine; Common Cold; Cough; Dextromethorpha | 2009 |
[Rhinitis acuta: therapeutic approach with oxymetazoline].
Topics: Administration, Intranasal; CD4-Positive T-Lymphocytes; Common Cold; Cytokines; Dendritic Cells; Dos | 2010 |
["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
Topics: Administration, Intranasal; Adult; Child, Preschool; Drug Combinations; Female; Hallucinations; Huma | 2011 |
[The curative effect of daphnlin spray on treating rhinitis].
Topics: Administration, Inhalation; Adolescent; Adult; Ephedrine; Female; Humans; Male; Middle Aged; Nasal D | 1999 |
CLINICAL COMPARISON OF OXYMETAZOLINE AND EPHEDRINE IN NASAL DECONGESTION.
Topics: Adolescent; Blood Pressure; Blood Pressure Determination; Drug Therapy; Ephedrine; Humans; Imidazole | 1965 |
[Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
Topics: Administration, Intranasal; Adrenergic alpha-Agonists; Capillary Permeability; Chronic Disease; Dose | 2006 |
Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells.
Topics: Cells, Cultured; Cytokines; Dendritic Cells; Dose-Response Relationship, Drug; Enzyme-Linked Immunos | 2007 |
Reference values for acoustic rhinometry in decongested school children and adults: the most sensitive measurement for change in nasal patency.
Topics: Adult; Airway Resistance; Anatomy, Cross-Sectional; Asthma; Child; Dermatitis, Atopic; Dust; Female; | 2007 |
Studies of blood flow in the human nasal mucosa.
Topics: Adult; Female; Histamine Release; Humans; Male; Nasal Mucosa; Oxymetazoline; Regional Blood Flow; Rh | 1983 |
The effect of a local decongestant in acute rhinitis as related to body position.
Topics: Acute Disease; Adolescent; Adult; Airway Resistance; Female; Humans; Imidazoles; Male; Oxymetazoline | 1983 |
[Rhinitis medicamentosa, an increasing problem. Do nose drops adversely affect bacterial infections?].
Topics: Administration, Intranasal; Adrenergic alpha-Agonists; Humans; Imidazoles; Oxymetazoline; Rhinitis | 1994 |
The impact of over-the-counter availability of nasal sprays on sales, prescribing, and physician visits.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Prescriptions; Female; Health Expenditures; H | 1999 |
[Therapeutic experience within the scope of a multicentric study using the new Nasivin-gel].
Topics: Adult; Drug Evaluation; Gels; Humans; Imidazoles; Oxymetazoline; Rhinitis | 1977 |
Effect of oxymetazoline nose drops on vascular permeability of the nasal mucosa in the rabbit after provocation with leukotriene B4.
Topics: Administration, Intranasal; Animals; Antibodies, Monoclonal; Capillary Permeability; Leukotriene B4; | 1992 |
The comparative nasal effects of prostaglandin D2 in normal and rhinitic subjects.
Topics: Airway Resistance; Humans; Hypersensitivity, Immediate; Manometry; Nasal Cavity; Nasal Provocation T | 1991 |
Neonatal respiratory distress from rhinitis medicamentosa.
Topics: Female; Humans; Infant, Newborn; Nasal Decongestants; Oxymetazoline; Phenylephrine; Respiratory Insu | 1987 |
A simple reversible cause of infant upper airway obstruction.
Topics: Administration, Intranasal; Airway Obstruction; Humans; Infant, Newborn; Male; Oxymetazoline; Rhinit | 1986 |
Nasal decongestants in otorhinolaryngology.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Nasal Decongestants; Oxymetazoline; Resp | 1966 |
Nasal decongestant therapy.
Topics: Biopsy; Chronic Disease; Epinephrine; Humans; Imidazoles; Nasal Decongestants; Oxymetazoline; Rhinit | 1967 |
A topical nasal decongestant for children.
Topics: Child, Preschool; Cresols; Female; Foreign Bodies; Fractures, Bone; Humans; Imidazoles; Infant; Male | 1968 |